JPWO2023073526A5 - - Google Patents
Info
- Publication number
- JPWO2023073526A5 JPWO2023073526A5 JP2024523575A JP2024523575A JPWO2023073526A5 JP WO2023073526 A5 JPWO2023073526 A5 JP WO2023073526A5 JP 2024523575 A JP2024523575 A JP 2024523575A JP 2024523575 A JP2024523575 A JP 2024523575A JP WO2023073526 A5 JPWO2023073526 A5 JP WO2023073526A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- aavhu
- aavrh
- pharmaceutical composition
- aav42
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271487P | 2021-10-25 | 2021-10-25 | |
| US63/271,487 | 2021-10-25 | ||
| PCT/IB2022/060189 WO2023073526A1 (en) | 2021-10-25 | 2022-10-24 | Methods for improving adeno-associated virus (aav) delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024539123A JP2024539123A (ja) | 2024-10-28 |
| JP2024539123A5 JP2024539123A5 (https=) | 2025-10-31 |
| JPWO2023073526A5 true JPWO2023073526A5 (https=) | 2025-10-31 |
Family
ID=84283163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523575A Pending JP2024539123A (ja) | 2021-10-25 | 2022-10-24 | アデノ随伴ウイルス（ａａｖ）送達を改善する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250235554A1 (https=) |
| EP (1) | EP4422613A1 (https=) |
| JP (1) | JP2024539123A (https=) |
| CN (1) | CN118043039A (https=) |
| WO (1) | WO2023073526A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2024071362A1 (https=) * | 2022-09-30 | 2024-04-04 | ||
| WO2025101959A1 (en) * | 2023-11-08 | 2025-05-15 | Renbio, Inc. | Plasmid dna constructs for peptide hormone expression |
| WO2025250457A1 (en) * | 2024-05-28 | 2025-12-04 | University Of Rochester | Enhanced brain transduction by gene therapeutics |
| CN118743768A (zh) * | 2024-06-13 | 2024-10-08 | 浙江大学 | 一种血小板-aav包装复合体及其制备方法和应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| WO1998033917A1 (en) | 1994-11-14 | 1998-08-06 | The Ludwig Institute For Cancer Research | Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
| US6410300B1 (en) | 1998-01-12 | 2002-06-25 | The University Of North Carolina At Chapel Hill | Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV |
| EP1751275B1 (en) | 2004-06-01 | 2017-08-16 | Avigen, Inc. | Compositions and methods to prevent aav vector aggregation |
| SI2548560T1 (sl) | 2005-06-23 | 2015-12-31 | Isis Pharmaceuticals, Inc. | Sestavki in postopki za moduliranje izrezovanja smn2 |
| US9415121B2 (en) | 2008-12-19 | 2016-08-16 | Nationwide Children's Hospital | Delivery of MECP2 polynucleotide using recombinant AAV9 |
| PT3305302T (pt) | 2009-06-17 | 2018-12-14 | Biogen Ma Inc | Composições e métodos de modulação de excisões de smn2 em um sujeito |
| EP2964270A4 (en) * | 2013-02-21 | 2017-03-22 | University Of Rochester | Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon |
| LT3702466T (lt) | 2013-08-27 | 2023-02-27 | Research Institute At Nationwide Children's Hospital | Produktai ir būdai, skirti šoninės amiotrofinės sklerozės gydymui |
| US9585971B2 (en) | 2013-09-13 | 2017-03-07 | California Institute Of Technology | Recombinant AAV capsid protein |
| EP3245221A4 (en) | 2015-01-16 | 2018-06-13 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| KR102423442B1 (ko) | 2015-12-11 | 2022-07-20 | 캘리포니아 인스티튜트 오브 테크놀로지 | 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드 |
| MX2020004830A (es) | 2017-11-08 | 2020-11-11 | Avexis Inc | Medios y metodo para preparar vectores virales y usos de los mismos. |
| TW202015742A (zh) | 2018-05-15 | 2020-05-01 | 美商航海家醫療公司 | 投遞腺相關病毒（ａａｖ）之組成物和方法 |
| EP3793615A2 (en) | 2018-05-16 | 2021-03-24 | Voyager Therapeutics, Inc. | Directed evolution of aav to improve tropism for cns |
| US20210207167A1 (en) | 2018-05-16 | 2021-07-08 | Voyager Therapeutics, Inc. | Aav serotypes for brain specific payload delivery |
| US20210277418A1 (en) | 2018-08-03 | 2021-09-09 | Voyager Therapeutics, Inc. | Aav variants with enhanced tropism |
| US12311035B2 (en) * | 2018-10-04 | 2025-05-27 | University Of Rochester | Glymphatic delivery by manipulating plasma osmolarity |
-
2022
- 2022-10-24 US US18/703,559 patent/US20250235554A1/en active Pending
- 2022-10-24 WO PCT/IB2022/060189 patent/WO2023073526A1/en not_active Ceased
- 2022-10-24 CN CN202280063874.4A patent/CN118043039A/zh active Pending
- 2022-10-24 JP JP2024523575A patent/JP2024539123A/ja active Pending
- 2022-10-24 EP EP22800804.1A patent/EP4422613A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7497247B2 (ja) | 組換えアデノ随伴ウイルス９の髄腔内送達 | |
| JP6417322B2 (ja) | 遺伝子治療ベクターの広範な遺伝子送達 | |
| Huang et al. | Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection | |
| AU2023202598B2 (en) | Intrathecal delivery of recombinant Adeno-associated virus encoding Methyl-CpG binding protein 2 | |
| JP2020533959A5 (https=) | ||
| AU2020270984A1 (en) | Gene therapies for lysosomal disorders | |
| JP2024539123A (ja) | アデノ随伴ウイルス（ａａｖ）送達を改善する方法 | |
| WO2022035903A2 (en) | Gene therapies for lysosomal disorders | |
| JP2021520811A (ja) | ヘキソサミニダーゼアルファおよびベータサブユニットをコードしているバイシストロニックａａｖベクターならびにその使用 | |
| JPWO2023073526A5 (https=) | ||
| CN114516901B (zh) | 一种神经系统高亲和性的aav载体及其应用 | |
| JPWO2020172490A5 (https=) | ||
| JPWO2022046988A5 (https=) | ||
| KR20250097939A (ko) | 투여 경로 | |
| CN116179605A (zh) | 一种重组腺相关病毒载体及其应用 | |
| TW202434729A (zh) | 含有星狀細胞導向啟動子構築體之合成核酸及其使用方法 | |
| JP2021527418A (ja) | ジストログリカノパチーおよびラミニン欠損筋ジストロフィーを治療するための組換えアデノ随伴ウイルス生成物および方法 | |
| JPWO2023183594A5 (https=) | ||
| HK40042522A (en) | Intrathecal delivery of recombinant adeno-associated virus 9 | |
| HK40004543A (en) | Intrathecal delivery of recombinant adeno-associated virus 9 | |
| CN110741079A (zh) | 病毒aav/igf2、基因治疗方法及其在亨廷顿氏病等蛋白质折叠错误相关疾病中的应用 | |
| WO2008130949A2 (en) | Modulating nurr1 expression in a cell |